RVMD Valuation

Revolution Medicines Inc

Add to Watchlist

Advanced Chart

58.840

-0.03(-0.051%)1D

RVMD Relative Valuation

RVMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RVMD is overvalued; if below, it's undervalued.

Historical Valuation

Revolution Medicines Inc (RVMD) is now in the Fair zone, suggesting that its current forward PS ratio of 58.84 is considered Fairly compared with the five-year average of -9.67. The fair price of Revolution Medicines Inc (RVMD) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：58.84

Fair

-9.89

Trailing

Forward

-7.35

EV/EBITDA

Revolution Medicines Inc. (RVMD) has a current EV/EBITDA of -7.35. The 5-year average EV/EBITDA is -6.98. The thresholds are as follows: Strongly Undervalued below -13.44, Undervalued between -13.44 and -10.21, Fairly Valued between -3.76 and -10.21, Overvalued between -3.76 and -0.53, and Strongly Overvalued above -0.53. The current Forward EV/EBITDA of -7.35 falls within the Historic Trend Line -Fairly Valued range.

-7.44

EV/EBIT

Revolution Medicines Inc. (RVMD) has a current EV/EBIT of -7.44. The 5-year average EV/EBIT is -6.94. The thresholds are as follows: Strongly Undervalued below -14.36, Undervalued between -14.36 and -10.65, Fairly Valued between -3.23 and -10.65, Overvalued between -3.23 and 0.47, and Strongly Overvalued above 0.47. The current Forward EV/EBIT of -7.44 falls within the Historic Trend Line -Fairly Valued range.

58.84

Revolution Medicines Inc. (RVMD) has a current PS of 58.84. The 5-year average PS is 2282.19. The thresholds are as follows: Strongly Undervalued below -9016.86, Undervalued between -9016.86 and -3367.33, Fairly Valued between 7931.71 and -3367.33, Overvalued between 7931.71 and 13581.23, and Strongly Overvalued above 13581.23. The current Forward PS of 58.84 falls within the Historic Trend Line -Fairly Valued range.

-10.12

P/OCF

Revolution Medicines Inc. (RVMD) has a current P/OCF of -10.12. The 5-year average P/OCF is -11.03. The thresholds are as follows: Strongly Undervalued below -20.50, Undervalued between -20.50 and -15.77, Fairly Valued between -6.29 and -15.77, Overvalued between -6.29 and -1.55, and Strongly Overvalued above -1.55. The current Forward P/OCF of -10.12 falls within the Historic Trend Line -Fairly Valued range.

-10.52

P/FCF

Revolution Medicines Inc. (RVMD) has a current P/FCF of -10.52. The 5-year average P/FCF is -10.76. The thresholds are as follows: Strongly Undervalued below -20.15, Undervalued between -20.15 and -15.45, Fairly Valued between -6.06 and -15.45, Overvalued between -6.06 and -1.37, and Strongly Overvalued above -1.37. The current Forward P/FCF of -10.52 falls within the Historic Trend Line -Fairly Valued range.

Revolution Medicines Inc (RVMD) has a current Price-to-Book (P/B) ratio of 5.90. Compared to its 3-year average P/B ratio of 3.63 , the current P/B ratio is approximately 62.56% higher. Relative to its 5-year average P/B ratio of 3.63, the current P/B ratio is about 62.59% higher. Revolution Medicines Inc (RVMD) has a Forward Free Cash Flow (FCF) yield of approximately -6.37%. Compared to its 3-year average FCF yield of -8.35%, the current FCF yield is approximately -23.75% lower. Relative to its 5-year average FCF yield of -7.99% , the current FCF yield is about -20.32% lower.

5.90

P/B

Median3y

3.63

Median5y

3.63

-6.37

FCF Yield

Median3y

-8.35

Median5y

-7.99

Competitors Valuation Multiple

The average P/S ratio for RVMD's competitors is 49.43, providing a benchmark for relative valuation. Revolution Medicines Inc Corp (RVMD) exhibits a P/S ratio of 58.84, which is 19.03% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

RVMD.O

Revolution Medicines Inc

Bausch Health Companies Inc

Cidara Therapeutics Inc

Performance Decomposition

Market capitalization of RVMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of RVMD in the past 1 year is driven by Unknown.